Replies to post #143043 on Biotech Values

[DewDiligence]

981 cancer drugs are currently in clinical development, according to PhRMA:

http://www.phrma.org/sites/default/files/1000/phrmamedicinesindevelopmentcancer2012.pdf

That’s 981 drugs, not 981 drug-indication pairs.

[DewDiligence]

Factoid—by 2020, 80% of cancer cases will be in emerging markets. (Tweeted by Steven Dickman, CEO of CBT Advisors, a biotech consulting firm.)